Adipose tissue endocannabinoid system gene expression: Depot differences and effects of diet and exercise

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  You, Tongjian ^a   Disanzo, Beth L ^b   Wang, Xuewen ^c   Yang, Rongze ^d   Gong, Dawei ^d  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoid Type 1 Receptor; Diet; Exercise; Fat Depots; Fatty Acid Amide Hydrolase

Indexed keywords

BETA ACTIN; CANNABINOID 1 RECEPTOR; FATTY ACID AMIDASE; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; AMIDASE; ENDOCANNABINOID; FATTY-ACID AMIDE HYDROLASE;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; AEROBIC CAPACITY; AEROBIC EXERCISE; AGED; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE INTENSITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIPID STORAGE; LOW CALORY DIET; MIDDLE AGED; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBESITY; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; BUTTOCK; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIET THERAPY; EXERCISE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SUBCUTANEOUS FAT;

COWBONE RIDGE VIRUS;

AGED; AMIDOHYDROLASES; BODY MASS INDEX; BUTTOCKS; COHORT STUDIES; DIET, REDUCING; ENDOCANNABINOIDS; EXERCISE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MIDDLE AGED; OBESITY; OVERWEIGHT; PHYSICAL EXERTION; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER; SUBCUTANEOUS FAT; SUBCUTANEOUS FAT, ABDOMINAL; WEIGHT LOSS;

EID: 80055012506     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-194     Document Type: Article

References (29)

1. A prospective study of obesity and risk of coronary heart disease in women. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH, N Engl J Med 1990 322 882 889 10.1056/ NEJM199003293221303 2314422 (Pubitemid 20108377)
2. Weight as a risk factor for clinical diabetes in women. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE, Am J Epidemiol 1990 132 501 513 2389754 (Pubitemid 20285148)
3. The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. Pagano C, Pilon C, Calcagno A, Urbanet R, Rossato M, Milan G, Bianchi K, Rizzuto R, Bernante P, Federspil G, Vettor R, J Clin Endocrinol Metab 2007 92 4810 4819 10.1210/jc.2007-0768 17785353 (Pubitemid 350223464)
4. The role of the endocannabinoid system in the control of energy homeostasis. Osei-Hyiaman D, Harvey-White J, Bátkai S, Bátkai S, Kunos G, Int J Obes (Lond) 2006 30 Suppl 1 33 S38
5. Dysregulation of the endocannabinoid system in obesity. Engeli S, J Neuroendocrinol 2008 20 Suppl 1 110 5 18426509 (Pubitemid 351559284)
6. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Starowicz KM, Cristino L, Matias I, Capasso R, Racioppi A, Izzo AA, Di Marzo V, Obesity (Silver Spring) 2008 16 553 565 10.1038/oby.2007.106 (Pubitemid 351328005)
7. Activation of the peripheral endocannabinoid system in human obesity. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM, Jordan J, Diabetes 2005 54 2838 2843 10.2337/diabetes.54.10.2838 16186383 (Pubitemid 41401077)
8. Cannabinoid physiology and pharmacology: 30 years of progress. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ, Neuropharmacology 2004 47 Suppl 1 345 358 15464149 (Pubitemid 39298276)
9. The molecular logic of endocannabinoid signalling. Piomelli D, Nat Rev Neurosci 2003 4 873 884 10.1038/nrn1247 14595399 (Pubitemid 37351427)
10. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Blüher M, Engeli S, Klöting N, Berndt J, Fasshauer M, Bátkai S, Pacher P, Schön MR, Jordan J, Stumvoll M, Diabetes 2006 55 3053 3060 10.2337/db06-0812 17065342 (Pubitemid 44923642)
11. Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients. Sarzani R, Bordicchia M, Marcucci P, Bedetta S, Santini S, Giovagnoli A, Scappini L, Minardi D, Muzzonigro G, Dess-Fulgheri P, Rappelli A, Metabolism 2009 58 361 367 10.1016/j.metabol.2008.10.009 19217452
12. Human adipose tissue cannabinoid receptor 1 gene expression is not related to fat cell function or adiponectin level. Löfgren P, Sjölin E, Wåhlen K, Hoffstedt J, J Clin Endocrinol Metab 2007 92 1555 1559 10.1210/jc.2006-2240 17284627 (Pubitemid 46556439)
13. Peripheral endocannabinoid system activity in patients treated with sibutramine. Engeli S, Heusser K, Janke J, Gorzelniak K, Bátkai S, Pacher P, Harvey-White J, Luft FC, Jordan J, Obesity (Silver Spring) 2008 16 1135 1137 10.1038/oby.2008.47 (Pubitemid 351620487)
14. Exercise activates the endocannabinoid system. Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A, Neuroreport 2003 14 2209 2211 10.1097/00001756-200312020-00015 14625449
15. ACSM's guidelines for exercise testing and prescription. Lippincott Williams & Wilkins, Philadelphia 8 2009
16. Addition of exercise training to dietary weight loss preferentially reduces abdominal adipocyte size. You T, Murphy KM, Lyles MF, Demons JL, Lenchik L, Nicklas BJ, Int J Obes 2006 30 1211 1216 10.1038/sj.ijo.0803245 (Pubitemid 44141609)
17. Weight regain is related to decreases in physical activity during weight loss. Wang X, Lyles MF, You T, Berry MJ, Rejeski WJ, Nicklas BJ, Med Sci Sports Exerc 2008 40 1781 1788 10.1249/MSS.0b013e31817d8176 18799988
18. Effect of exercise intensity on abdominal fat loss during calorie restriction in overweight and obese postmenopausal women: a randomized, controlled trial. Nicklas BJ, Wang X, You T, Lyles MF, Demons J, Easter L, Berry MJ, Lenchik L, Carr JJ, Am J Clin Nutr 2009 89 1043 1052 10.3945/ajcn.2008. 26938 19211823
19. Resting energy expenditure changes with weight loss: racial differences. Wang X, You T, Lenchik L, Nicklas BJ, Obesity (Silver Spring) 2010 18 86 91 10.1038/oby.2009.163
20. The effects of training on heart rate; a longitudinal study. Karvonen MJ, Kentala E, Mustala O, Ann Med Exp Biol Fenn 1957 35 307 315 13470504
21. Endocannabinoids and the regulation of their levels in health and disease. Di Marzo V, Petrosino S, Curr Opin Lipidol 2007 18 129 140 10.1097/MOL.0b013e32803dbdec 17353660 (Pubitemid 46412082)
22. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. Spoto B, Fezza F, Parlongo G, Battista N, Sgro' E, Gasperi V, Zoccali C, Maccarrone M, Biochimie 2006 88 1889 1897 10.1016/j.biochi.2006.07.019 16949718 (Pubitemid 44881190)
23. Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity. Kempf K, Hector J, Strate T, Schwarzloh B, Rose B, Herder C, Martin S, Algenstaedt P, Horm Metab Res 2007 39 596 600 10.1055/s-2007-984459 17712725 (Pubitemid 47345235)
24. The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. Pagano C, Pilon C, Calcagno A, Urbanet R, Rossato M, Milan G, Bianchi K, Rizzuto R, Bernante P, Federspil G, Vettor R, J Clin Endocrinol Metab 2007 92 4810 4819 10.1210/jc.2007-0768 17785353 (Pubitemid 350223464)
25. Insulin differentially modulates the peripheral ndocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals. Murdolo G, Kempf K, Hammarstedt A, Herder C, Smith U, Jansson PA, J Endocrinol Invest 2007 30 C17 RC21 17923791
26. Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans. Bordicchia M, Battistoni I, Mancinelli L, Giannini E, Refi G, Minardi D, Muzzonigro G, Mazzucchelli R, Montironi R, Piscitelli F, Petrosino S, Dess-Fulgheri P, Rappelli A, Di Marzo V, Sarzani R, Metabolism 2010 59 734 741 10.1016/j.metabol.2009.09.018 19919870
27. The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans. Cable JC, Tan GD, Alexander SP, O'Sullivan SE, Lipids Health Dis 2011 10 129 10.1186/1476-511X-10-129 21813022
28. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss. Bennetzen MF, Wellner N, Ahmed SS, Ahmed SM, Diep TA, Hansen HS, Richelsen B, Pedersen SB, Int J Obes (Lond) 2011
29. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta. Yan ZC, Liu DY, Zhang LL, Shen CY, Ma QL, Cao TB, Wang LJ, Nie H, Zidek W, Tepel M, Zhu ZM, Biochem Biophys Res Commun 2007 354 427 433 10.1016/j.bbrc.2006.12.213 17223076 (Pubitemid 46172454)